JDD Issue Highlights | June 2022: Acne & Rosacea
The June 2022 issue of the Journal of Drugs in Dermatology (JDD) focuses on acne and rosacea, with original articles discussing topics such as improving rosacea outcomes in skin of color patients, pediatric and female acne, topical management of facial and truncal acne, and many more. Included in this issue are also case reports on bullous dermatitis and low dose Naltrexone in combination with PRP …
The June 2022 issue of the Journal of Drugs in Dermatology (JDD) focuses on acne and rosacea, with original articles discussing topics such as improving rosacea outcomes in skin of color patients, pediatric and female acne, topical management of facial and truncal acne, and many more. Included in this issue are also case reports on bullous dermatitis and low dose Naltrexone in combination with PRP … Continue reading "JDD Issue Highlights | June 2022: Acne & Rosacea"
Dr. Diane Thiboutot, Professor of Dermatology at The Pennsylvania State University College of Medicine, gave a practical talk at the 2022 ODAC Dermatology, Aesthetic and Surgical Conference about hormonal treatment of acne. Dr. Thiboutot discussed the hormonal work up, indications for hormonal treatment, and guidelines for choosing a therapy, including oral contraceptives.
Hormonal Workup for Ac … 
Overcoming Barriers to Acne Treatment Adherence
There is a wealth of research into the psychology of the acne patient, which may be used to speak with patients more effectively and ultimately lead to better treatment outcomes. Despite the fact that acne has a high emotional impact on patients, adherence to acne treatment plans is surprisingly low (in 1 study, 27% of patients didn’t even fill th … 
The June issue of the Journal of Drugs in Dermatology focuses on the topics of acne and rosacea, and features additional articles on topics such as atopic dermatitis and psoriasis. Straight from the JDD Editor’s desk, we share this month’s issue highlights:
Guest Editor James Q. Del Rosso discusses roadblocks that impede patient ability to obtain medications selected by their dermatologist … 
Straight from the desk of ODAC Medical Director, Dr. Adam Friedman, we share what’s popping in acne (spoiler alert: quite a lot!). According to Dr. Friedman, the innovation drought is over! Watch as he reviews all new topical and oral therapeutics (some of which are completely new active agents) and while at it, shares and debunks important information related to the management of acne vulgaris … 